Loading organizations...
§ Venture Capital · Suzhou, Jiangsu, China
Yuansheng Capital operates as a venture capital firm, providing strategic investment and support to emerging enterprises. The firm focuses on early and growth stage opportunities within the life science and healthcare sectors. It aims to accelerate innovative technology development and solution delivery by leveraging specialized industry insights.
The firm was established in 2015 by Peng Zhijian, a former executive at Tencent Holdings Ltd. Zhijian’s insight recognized the substantial potential and critical demands within the evolving life science and healthcare industries. This understanding led to the creation of a dedicated investment platform, fostering breakthroughs in these vital sectors.
Yuansheng Capital primarily serves innovative, early and growth-stage companies across the life science and healthcare spectrum. Through strategic investments, the firm empowers these entities to advance groundbreaking research and impactful products. Its vision is to catalyze transformative progress within the global health and biomedical innovation landscape.
Key people at Yuan Sheng Capital.
Yuan Sheng Capital has 3 tracked investments across 3 companies. The latest tracked deal is $4.3B Series A in BCIFlex in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2026 | BCIFlex | $4.3B Series A | 中科创星 | Baidu Ventures, Beijing Pharmaceutical And Health Industry Investment Fund, DragonBall Capital, Hongshan Capital Group (Sequoia Capital China), IDG Capital, JIA YIN Capital, Legend Capital, Lenovo Capital, Shunwei Capital, Xingze Capital |
| Nov 11, 2021 | Changmugu Medical | $84.5M Series B | CDH Investments, CICC Capital, Yikun LIU | China Development Qihang |
| Nov 1, 2017 | Iron Armour | $44.0M Series D | Yuan YI Capital | INCE Capital, Qiming Venture Partners, Tiger Global Management, DCM, Kuan DAI Capital |
Key people at Yuan Sheng Capital.